Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Austin L. Chiang, M.D., M.P.H. joins Medtronic as Chief Medical Officer for Gastrointestinal business

10/22/2021 | 07:55am EST

DUBLIN - Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced Austin L. Chiang, M.D., M.P.H., assistant professor of medicine at Sidney Kimmel Medical College, chief medical social media officer of Jefferson Health and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, has joined Medtronic as Chief Medical Officer (CMO) of the Gastrointestinal (GI) business at Medtronic.

In this role, Dr. Chiang will provide medical expertise and strategic guidance on evidence development, clinical communications and publications, and training and support needs. Additionally, he will provide oversight to ensure patient safety throughout product lifecycle, including the product development processes, risk management, clinical trials, and safety surveillance. Dr. Chiang is one of the few triple board-certified advanced endoscopy-trained physicians in the world. His certifications include Internal Medicine and Gastroenterology by the American Board of Internal Medicine, and in Obesity Medicine by the American Board of Obesity Medicine.

'As healthcare continues to evolve at such a rapid pace, we are excited to add a clinician of Dr. Chiang's caliber to our leadership team,' said Giovanni Di Napoli, president of the Gastrointestinal business, which is part of the Medical Surgical Portfolio at Medtronic. 'Dr. Chiang's approach to medicine and educating healthcare providers and patients is on the leading edge of healthcare innovation. His forward thinking and desire to personalize medicine for patients and providers will help Medtronic to continue evolving and serving the ever-changing healthcare community.'

'I am thrilled to be joining Medtronic at such an innovative time in healthcare and especially in the gastrointestinal space, helping to deliver on what is a promising future for those in need of innovative GI care around the world,' said Dr. Chiang. 'I look forward to joining a world-renowned team of brilliant engineers and leading clinical experts that produce life-saving devices. I anticipate collaborating with our Medtronic team across the globe to produce solutions that best serve patients and increase quality of care for all.'

In addition to serving as Chief Medical Officer for the Medtronic GI business, Dr. Chiang will continue to practice clinically at Jefferson Health. 'This is a great step in Dr. Chiang's career as a Jefferson faculty member, and as one of the nation's leading science advocates,' said Stephen K. Klasko, M.D., MBA, president of Thomas Jefferson University and CEO of Jefferson Health. 'This new role allows him to marry clinical care and device innovation, and to use technology as the foundation for the revolution in putting people first in health care delivery.'

A nationally recognized gastroenterologist and advanced endoscopist, Dr. Chiang is passionate about empowering patients with accurate medical information online. He serves on the board of the Association for Bariatric Endoscopy (ABE) and is a committee member for the American College of Gastroenterology (ACG) and the American Society for Gastrointestinal Endoscopy (ASGE). He is also founding president of the Association for Healthcare Social Media (AHSM). Dr. Chiang was named Healio Gastroenterology's Disruptive Innovator of the Year in 2018 and was a Philadelphia Inquirer Influencer of Healthcare Rookie of the Year in 2019. This year, Dr. Chiang was a nominee for the GLAAD Media TikTok Advocate of the Year award.

Dr. Chiang completed his undergraduate degree in Biology at Duke University, and he earned his Medical Doctorate from Columbia University before completing his internal medicine residency at New York Presbyterian Hospital (Columbia University). He completed his gastroenterology and bariatric endoscopy fellowships at Brigham and Women's Hospital/Harvard Medical School and advanced endoscopy fellowship at Thomas Jefferson University Hospital. He is also a graduate of the Harvard T.H. Chan School of Public Health where he earned his master's degree in Public Health.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for all. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com(opens new window) and follow @Medtronic(opens new window) on Twitter and LinkedIn(opens new window).

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.


Sabrina Zimring

Public Relations

T: +1-720-774-3454

Ryan Weispfenning

Investor Relations

T: +1-763-505-4626

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about MEDTRONIC PLC
11/24JPMorgan Adjusts Medtronic's Price Target to $130 from $148, Keeps Overweight Rating
11/24Bernstein Adjusts Medtronic's Price Target to $143 from $148, Keeps Outperform Rating
11/24Raymond James Adjusts Medtronic's Price Target to $127 from $142, Keeps Outperform Rati..
11/24Stifel Adjusts Medtronic's Price Target to $140 from $145, Keeps Buy Rating
11/24Truist Securities Adjusts Medtronic's Price Target to $142 from $148, Keeps Buy Rating
11/24Wells Fargo Adjusts Medtronic's Price Target to $137 From $144, Reiterates Overweight R..
11/24Oppenheimer Adjusts Price Target on Medtronic to $145 From $150, Maintains Outperform R..
11/24Morgan Stanley Adjusts Price Target on Medtronic to $145 From $154, Maintains Overweigh..
11/24Citigroup Adjusts Medtronic's Price Target to $146 From $153, Reiterates Buy Rating
11/23Needham Adjusts Medtronic's Price Target to $145 From $152, Maintains Buy Rating
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 396 M - -
Net income 2022 5 378 M - -
Net Debt 2022 22 296 M - -
P/E ratio 2022 28,4x
Yield 2022 2,26%
Capitalization 149 B 149 B -
EV / Sales 2022 5,30x
EV / Sales 2023 4,90x
Nbr of Employees 90 000
Free-Float 99,8%
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 27
Last Close Price 111,05 $
Average target price 141,32 $
Spread / Average Target 27,3%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC-5.20%153 906
DEXCOM, INC.61.90%58 016